The 10 analysts offering 12-month price forecasts for Karuna Therapeutics Inc have a median target of 118.50, with a high estimate of 134.00 and a low estimate of 105.00. The median estimate represents a +36.62% increase from the last price of 86.74.
The current consensus among 10 polled investment analysts is to Buy stock in Karuna Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.47
Reporting Date Aug 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.